JP2004500037A5 - - Google Patents

Info

Publication number

JP2004500037A5

JP2004500037A5 JP2001521746A JP2001521746A JP2004500037A5 JP 2004500037 A5 JP2004500037 A5 JP 2004500037A5 JP 2001521746 A JP2001521746 A JP 2001521746A JP 2001521746 A JP2001521746 A JP 2001521746A JP 2004500037 A5 JP2004500037 A5 JP 2004500037A5

Authority

JP

Japan

Prior art keywords

fgf

polypeptide

seq

nucleic acid

amino acid

Prior art date

2000-03-09

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 102100031734 Fibroblast growth factor 19 Human genes 0.000 description 43
• 101000846394 Homo sapiens Fibroblast growth factor 19 Proteins 0.000 description 43
• 238000000034 method Methods 0.000 description 26
• 239000003814 drug Substances 0.000 description 24
• 150000007523 nucleic acids Chemical class 0.000 description 23
• 102000039446 nucleic acids Human genes 0.000 description 22
• 108020004707 nucleic acids Proteins 0.000 description 22
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 21
• 108020004414 DNA Proteins 0.000 description 18
• 125000003275 alpha amino acid group Chemical group 0.000 description 15
• 210000004027 cell Anatomy 0.000 description 13
• 229940079593 drug Drugs 0.000 description 13
• 102000053602 DNA Human genes 0.000 description 11
• 108090000765 processed proteins & peptides Proteins 0.000 description 11
• 229920001184 polypeptide Polymers 0.000 description 10
• 102000004196 processed proteins & peptides Human genes 0.000 description 10
• 125000000539 amino acid group Chemical group 0.000 description 7
• 239000002299 complementary DNA Substances 0.000 description 6
• 239000012867 bioactive agent Substances 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 5
• 239000003937 drug carrier Substances 0.000 description 5
• 239000000203 mixture Substances 0.000 description 5
• 239000002773 nucleotide Substances 0.000 description 5
• 125000003729 nucleotide group Chemical group 0.000 description 5
• 108090000144 Human Proteins Proteins 0.000 description 4
• 102000003839 Human Proteins Human genes 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 210000001789 adipocyte Anatomy 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 3
• 102000016267 Leptin Human genes 0.000 description 3
• 108010092277 Leptin Proteins 0.000 description 3
• 230000004190 glucose uptake Effects 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 3
• 229940039781 leptin Drugs 0.000 description 3
• 208000008589 Obesity Diseases 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 239000005557 antagonist Substances 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 235000020824 obesity Nutrition 0.000 description 2
• 102000004169 proteins and genes Human genes 0.000 description 2
• 108090000623 proteins and genes Proteins 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 108091028043 Nucleic acid sequence Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 230000000536 complexating effect Effects 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 235000021588 free fatty acids Nutrition 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 239000010871 livestock manure Substances 0.000 description 1
• 230000037323 metabolic rate Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1